Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer™
January 15, 2021 16:59 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received a “not-approvable”...